Search Results - "MASUDA, Daisaku"

Postprandial Hyperlipidemia and Remnant Lipoproteins by Masuda, Daisaku, Yamashita, Shizuya

“…Fasting hypertriglyceridemia is positively associated with the morbidity of coronary heart disease (CHD), and postprandial (non-fasting) hypertriglyceridemia…”
Get full text

Triglyceride Level and Cardiovascular Risk Reduction Using Pemafibrate Compared with Fibrates by Masuda, Daisaku

Get full text

Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases by Yamashita, Shizuya, Masuda, Daisaku, Matsuzawa, Yuji

“…Fasting and postprandial hypertriglyceridemia is a risk factor for atherosclerotic cardiovascular diseases (ASCVD). Fibrates have been used to treat…”
Get full text

Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease by Masuda, Daisaku, Yamashita, Shizuya

Get full text

New Horizons for Probucol, an Old, Mysterious Drug by Yamashita, Shizuya, Masuda, Daisaku, Matsuzawa, Yuji

“…[See article vol.28 : 124-136] Intensive low-density lipoprotein (LDL)-lowering therapies involving statins, intestinal cholesterol transporter inhibitor…”
Get full text

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022 by Okamura, Tomonori, Tsukamoto, Kazuhisa, Arai, Hidenori, Fujioka, Yoshio, Ishigaki, Yasushi, Koba, Shinji, Ohmura, Hirotoshi, Shoji, Tetsuo, Yokote, Koutaro, Yoshida, Hiroshi, Yoshida, Masayuki, Deguchi, Juno, Dobashi, Kazushige, Fujiyoshi, Akira, Hamaguchi, Hirotoshi, Hara, Masumi, Harada-Shiba, Mariko, Hirata, Takumi, Iida, Mami, Ikeda, Yoshiyuki, Ishibashi, Shun, Kanda, Hideyuki, Kihara, Shinji, Kitagawa, Kazuo, Kodama, Satoru, Koseki, Masahiro, Maezawa, Yoshiro, Masuda, Daisaku, Miida, Takashi, Miyamoto, Yoshihiro, Nishimura, Rimei, Node, Koichi, Noguchi, Midori, Ohishi, Mitsuru, Saito, Isao, Sawada, Shojiro, Sone, Hirohito, Takemoto, Minoru, Wakatsuki, Akihiko, Yanai, Hidekatsu

“…[Preamble] Atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease (CAD), such as acute myocardial infarction and angina pectoris,…”
Get full text

Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin by Masuda, Daisaku, Yamashita, Shizuya

Get full text

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study by Yamashita, Shizuya, Masuda, Daisaku, Harada-Shiba, Mariko, Arai, Hidenori, Bujo, Hideaki, Ishibashi, Shun, Daida, Hiroyuki, Koga, Nobuhiko, Oikawa, Shinichi

“…Aims: Familial hypercholesterolemia (FH) is a genetic disorder characterized by high serum levels of low-density lipoprotein (LDL)-cholesterol (LDL-C), tendon…”
Get full text

Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study by Ogura, Masatsune, Harada-Shiba, Mariko, Masuda, Daisaku, Arai, Hidenori, Bujo, Hideaki, Ishibashi, Shun, Daida, Hiroyuki, Koga, Nobuhiko, Oikawa, Shinichi, Yamashita, Shizuya

“…Aims: Familial hypercholesterolemia (FH) is characterized by high low-density lipoprotein (LDL) cholesterol levels, xanthomas including Achilles tendon…”
Get full text

Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction by Liu, Jingyi, Nishida, Makoto, Inui, Hiroyasu, Chang, Jiuyang, Zhu, Yinghong, Kanno, Kotaro, Matsuda, Hibiki, Sairyo, Masami, Okada, Takeshi, Nakaoka, Hajime, Ohama, Tohru, Masuda, Daisaku, Koseki, Masahiro, Yamashita, Shizuya, Sakata, Yasushi

“…Aim: A direct oral anti-coagulant, FXa inhibitor, has been applied to the clinical treatment of myocardial infarction (MI). Experimental studies in mice…”
Get full text

Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study by Naito, Ryo, Daida, Hiroyuki, Masuda, Daisaku, Harada-Shiba, Mariko, Arai, Hidenori, Bujo, Hideaki, Ishibashi, Shun, Koga, Nobuhiko, Oikawa, Shinichi, Yamashita, Shizuya

“…Aims: Lipoprotein(a) [Lp(a)] is a plasma lipoprotein consisting of a low-density lipoprotein (LDL)–like particle with apolipoprotein (Apo)(a), attached via a…”
Get full text

Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report by Iitake, Chie, Masuda, Daisaku, Koseki, Masahiro, Yamashita, Shizuya

“…Currently available treatments have only been partly successful in patients with severe hypertriglyceridemia, including those with high serum triglycerides…”
Get full text

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE) by Yamashita, Shizuya, Arai, Hidenori, Bujo, Hideaki, Masuda, Daisaku, Ohama, Tohru, Ishibashi, Toshiyuki, Yanagi, Koji, Doi, Yasuji, Nakagawa, Satoshi, Yamashiro, Koichi, Tanabe, Kenichiro, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji, on Behalf of the PROSPECTIVE Study Group

“…Aims: Although intensive statin therapy reduced cardiovascular risks, cardiovascular events have not been completely prevented. Probucol is a potent…”
Get full text

Very High Levels of High-Density Lipoprotein Cholesterol and Cardiovascular Events in Japanese Population by Masuda, Daisaku, Yamashita, Shizuya

“…[See article vol. 23: 800-809]A reduction in plasma high-density lipoprotein cholesterol (HDL-C) level accelerated the frequency of cardiovascular (CV) event,…”
Get full text

Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein by Okada, Takeshi, Sumida, Mizuki, Ohama, Tohru, Katayama, Yuki, Saga, Ayami, Inui, Hiroyasu, Kanno, Kotaro, Masuda, Daisaku, Koseki, Masahiro, Nishida, Makoto, Sakata, Yasushi, Yamashita, Shizuya

“…Aims: HDL particles have various anti-atherogenic functions, whereas HDL from atherosclerotic patients was demonstrated to be dysfunctional. One possible…”
Get full text

Cultural Barriers in the Treatment of Dyslipidemia: A Survey of Japanese Physician Attitudes by Yamashita, Shizuya, Masuda, Daisaku, Arai, Hidenori, Matsuzawa, Yuji

“…Aims: To gain a more accurate understanding of the current real-world management of dyslipidemia in Japan, an online survey was conducted in a variety of…”
Get full text

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate by Yamashita, Shizuya, Okazaki, Mitsuyo, Okada, Takeshi, Masuda, Daisaku, Yokote, Koutaro, Arai, Hidenori, Araki, Eiichi, Ishibashi, Shun

“…Aim:We established a method to evaluate the lipid concentrations, size and particle numbers (PNs) of lipoprotein subclasses by gel permeation chromatography…”
Get full text

Current Diagnosis and Management of Primary Chylomicronemia by Okazaki, Hiroaki, Gotoda, Takanari, Ogura, Masatsune, Ishibashi, Shun, Inagaki, Kyoko, Daida, Hiroyuki, Hayashi, Toshio, Hori, Mika, Masuda, Daisaku, Matsuki, Kota, Yokoyama, Shinji, Harada-Shiba, Mariko

“…Primary chylomicronemia (PCM) is a rare and intractable disease characterized by marked accumulation of chylomicrons in plasma. The levels of plasma…”
Get full text

Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT by Arai, Hidenori, Bujo, Hideaki, Masuda, Daisaku, Ishibashi, Toshiyuki, Nakagawa, Satoshi, Tanabe, Kenichiro, Kagimura, Tatsuo, Kang, Hyun-Jae, Kim, Moo Hyun, Sung, Jidong, Kim, Sang-Hyun, Kim, Cheol-Ho, Park, Jeong Euy, Ge, Junbo, Oh, Byung-Hee, Kita, Toru, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji, Yamashita, Shizuya

“…Aims: In this study, we integrated two randomized control trials, PROSPECTIVE and IMPACT, to address the effect of probucol on cerebrocardiovascular events and…”
Get full text

Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography by Masuda, Daisaku, Kiyosue, Arihiro, Hirayama, Atsushi, Shimauchi, Junichiro, López, J. Antonio G., Miyawaki, Kazumasa, Yamashita, Shizuya

“…Aims: Profiling of lipoproteins can predict risk of cardiovascular disease; gel permeation high-performance liquid chromatography (HPLC) improves prediction…”
Get full text